Diminished antibody response to SARS-CoV-2 in rheumatoid arthritis compared to metabolic disorders following the primary series of vaccinations and its recovery with a booster: A single-center prospective observational study.
Hidetomo SatoKatsuya NagataniSeiji MinotaPublished in: International journal of rheumatic diseases (2024)
MD did not exhibit a significant impact on antibody responses in RA patients. The reduced antibody response following the primary series in RA patients appeared to be attributed more to specific RA medications rather than to the disease itself. Booster vaccines are vital in restoring the antibody response in RA.
Keyphrases
- rheumatoid arthritis
- end stage renal disease
- sars cov
- disease activity
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- ankylosing spondylitis
- interstitial lung disease
- patient reported outcomes
- systemic lupus erythematosus
- molecular dynamics
- systemic sclerosis
- idiopathic pulmonary fibrosis